ANNUAL REPORT 2026 Corporate Directory References in this Annual Report Unless otherwise stated, references in this Annual Report to “PYC” or the “Company” are to PYC Therapeutics Ltd, and references to the “Group” are to PYC Therapeutics Ltd and its controlled...
2026 Annual Report to Shareholders
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Story so far
Earlier from PYC Therapeutics
- Appendix 4E
- Notification regarding unquoted securities - PYC
- Investor Webinar
- Change of Director's Interest Notice
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from PYC Therapeutics
- Appendix 4G
- 2026 Corporate Governance Statement
- PKD - Presentation of Clinical Safety Data
- Ceasing to be a substantial holder
- ADOA Program - Data Presentation
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics